Correction to: Remarkable clinical responses of non-fluctuating Parkinson's disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ~ 300 mg/day to opicapone 25 mg/day.

Nakamagoe, Kiyotaka; Tsuji, Hiroshi; Ishii, Kazuhiro; Tamaoka, Akira

Nakamagoe, Kiyotaka; Tsuji, Hiroshi; Ishii, Kazuhiro; Tamaoka, Akira.

Afiliação

Nakamagoe K; Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. nakamagoek@md.tsukuba.ac.jp.
Tsuji H; Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Ishii K; Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Tamaoka A; Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Neurol Sci ; 42(11): 4859, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34398370

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google